AKANDA CORP. Logo

AKANDA CORP.

Cultivates and distributes pharma-quality medical cannabis for patients in legal markets worldwide.

AKAN | US

Overview

Corporate Details

ISIN(s):
CA00971M1068
LEI:
Country:
United States of America
Address:
1A, 1B LEAROYD ROAD, NEW ROMNEY
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Akanda Corp. is an international medical cannabis company engaged in the cultivation, manufacturing, and distribution of premium cannabis products. The company's mission is to provide high-quality, medicinal-grade cannabis and wellness products to patients in legal markets worldwide. Akanda operates cultivation and processing facilities, including a significant operation in the Kingdom of Lesotho and a facility in Portugal, to produce pharma-quality, non-irradiated cannabis flower. Through subsidiaries like UK-based distributor CanMart, the company supplies its products to international markets. Akanda also leverages strategic partnerships for world-class genetics to enhance its product offerings for patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all AKANDA CORP. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AKANDA CORP.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AKANDA CORP. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NEUROCRINE BIOSCIENCES INC Logo
Develops therapies for neurological, neuroendocrine, and neuropsychiatric disorders.
United States of America NBIX
Neurogene Inc. Logo
Developing genetic medicines using gene therapy for rare and devastating neurological diseases.
United States of America NGNE
NeuroSense Therapeutics Ltd. Logo
Developing combination therapies for neurodegenerative diseases, with a focus on ALS.
United States of America NRSN
NewAmsterdam Pharma Co N.V. Logo
Developing oral LDL-lowering therapies for high-risk cardiovascular disease patients.
United States of America NAMS
Newbury Pharmaceuticals AB Logo
Develops specialty prescription drugs for Scandinavia in oncology, rare diseases & neurology.
Sweden NEWBRY
New Nordic Healthbrands AB Logo
Develops and markets herbal supplements & beauty products for natural wellness consumers globally.
Sweden NNH
Newron Pharmaceuticals S.p.A. Logo
Biopharma developing novel therapies for nervous system diseases like Parkinson's and schizophrenia.
Italy NWRN
NEXGEL, INC. Logo
Develops and manufactures advanced hydrogels for healthcare, OTC, and consumer applications.
United States of America NXGL
NextCell Pharma AB Logo
Develops off-the-shelf cell therapies for autoimmune diseases like type 1 diabetes.
Sweden NXTCL
NextCure, Inc. Logo
Clinical-stage biopharma developing novel immunomedicines for cancer and other diseases.
United States of America NXTC

Talk to a Data Expert

Have a question? We'll get back to you promptly.